A radical new approach to policy news and analysis. Subscribe at AxiosPro.com.
Axios Pro: Policy
Internet News
A radical new approach to policy news and analysis. Follow for key policy updates. Subscribe at AxiosPro.com.
About us
Your behind the scenes pass into the halls of Congress. Receive real-time analysis when critical news breaks, plus exclusive interviews, committee insights, networking events and more. Subscribe at AxiosPro.com.
- Website
-
https://www.axios.com/pro
External link for Axios Pro: Policy
- Industry
- Internet News
- Company size
- 501-1,000 employees
- Type
- Privately Held
Updates
-
💡 Sen. J.D. Vance solidifies Donald Trump's pitch for protectionism and anti-China economic policy that seeks to bolster the U.S. energy sector, Nick Sobczyk writes. Why it matters: Vance's nomination for vice president makes for the most hawkish ticket on trade in recent memory and deepens the campaign's ties to the anti-ESG movement. Driving the news: Vance could now have a prominent voice in the debate about how Republicans should scale back the #IRA and whether they should repeal it wholesale. Read the full story + analysis from #Energy Policy reporter Nick Sobczyk on AxiosPro.com: https://lnkd.in/efM6cui9
-
🤖 Former President Trump has tapped J.D. Vance to be his running mate in the 2024 presidential election, and the senator brings a tech track record with him that could leave big companies rattled. Why it matters: Vance belongs to the group of conservatives who are sympathetic to the idea that Big Tech companies should be broken up because he thinks they wield too much power. If he has Trump's ear on this issue, accusations of tech censorship may rise and antitrust enforcement could stay aggressive. Read the full story + analysis from #Tech Policy reporters Maria Curi and Ashley Gold on AxiosPro.com: https://lnkd.in/ejiHN4V9
Where J.D. Vance stands on tech policy
axios.com
-
⚕ Sen. J.D. Vance doesn't adhere to traditional GOP orthodoxy on #healthcare, staking out populist positions on issues like drug pricing while shying away from a full-throated repeal of the Affordable Care Act. Here's a closer look at where he stands on key issues from Health Care Policy reporters Peter Sullivan and Victoria Knight. Read it now on AxiosPro.com: https://lnkd.in/e5aU6Dj4
What J.D. Vance means for health policy
axios.com
-
NEXT WEEK: Join Axios co-founder Mike Allen and Quorum co-founder and CEO Alex Wirth for a fireside chat covering changes happening in public affairs. Reserve your spot today: https://lnkd.in/gcJsPZJk
Insights from Axios & Quorum: Navigating Change in Public Affairs | Quorum
quorum.us
-
🚨 Exclusive: The tech industry is laying out its hopes for the next president in a letter shared exclusively with Axios. Why it matters: Industry groups representing a sprawling set of entities and interests are calling for the next administration to support the "trustworthy development and adoption" of #AI, quantum and immersive technologies. Driving the news: In a letter and "presidential platform" document sent to the Biden and Trump campaigns Thursday, the groups say they want the next president to invest in #STEM-based skills training, welcome high-skilled immigrants to the workforce and improve federal hiring and retention. Read the full story from Tech Policy Reporter Maria Curi on AxiosPro.com: https://lnkd.in/ebSX7meP
Exclusive: Tech's wishlist for the next president
axios.com
-
Axios Pro: Policy reposted this
As the regulated community and the #EPA grapple with a post-Chevron doctrine world, #environmental litigator Jon Katchen shares with Axios Pro: Policy, “The idea that the sky is falling, I think, is overstated," adding “Even in lower courts that had been using Chevron, there wasn't a consistent application of the doctrine." Read here: https://lnkd.in/gebyGkUs #ChevronDoctrine
-
-
🚨 SCOOP: Executives from the three biggest PBMs will testify at the House Oversight Committee on July 23, the panel confirmed to Axios. Why it matters: The hearing adds to mounting bipartisan scrutiny of PBMs as lawmakers consider a flurry of legislation aimed at lowering drug costs by targeting certain PBM business practices. Driving the news: House Oversight spokesperson Jessica Collins told Axios executives from CVS Caremark, Express Scripts and OptumRx have agreed to testify at the hearing. Read the story from Health Care Policy reporter Peter Sullivan on AxiosPro.com: https://lnkd.in/gmj_8fsF
Scoop: PBM execs to testify on July 23
axios.com
-
🏛 Analysis: This will be a big month for appropriations watchers, and those of you who are watching telehealth and a proposed 340B overhaul could be busy too. Why it matters: Tired of doomscrolling about the presidential race? Then relax with some nice, normal health care policy fights. Read the full story + analysis from Health Care Policy reporters Victoria Knight & Peter Sullivan on AxiosPro.com: https://lnkd.in/geXw6VC7
What we're watching for health policy in July
axios.com
-
Axios Pro: Policy reposted this
Today, Quorum and Axios, two of the leading brands in public affairs, have partnered to bring Axios Pro: Policy’s real-time policy news to Quorum’s best-in-class public affairs software. 🗞️ What's New: Axios Pro's cutting-edge policy news and analysis is now available directly in Quorum Federal. Why it matters: Public affairs professionals like you work best when you can get information and execute strategy, all in one place. Now, bring the hyper-relevant policy news from Axios Pro’s Healthcare, Energy, and Tech verticals into your legislative tracking workflow in Quorum to inform your advocacy strategy. Learn more about Axios policy news in Quorum at the link in the comments.